Browse the evidence

Weekly subcutaneous semaglutide at 2.4 mg reduces the risk of major adverse cardiovascular events (death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke) in patients with obesity or overweight and preexisting cardiovascular disease, regardless of diabetes status.

If you have heart disease and are overweight or obese, but do not have diabetes, adding once-weekly semaglutide (2.4 mg) to your standard heart care significantly lowers your risk of heart attack, stroke, or heart-related death. The treatment involves a slow buildup of the dose over 16 weeks to manage side effects like nausea. While it works well for most, be aware that gastrointestinal issues are the main reason people stop taking it.

Replacing saturated fat (SFA) with polyunsaturated fat (PUFA) in the diet significantly reduces the risk of coronary heart disease (CHD) events, with a risk reduction of approximately 10% for every 5% of energy increased in PUFA intake.

To lower your risk of heart disease, swap saturated fats (found in animal products and some tropical oils) for polyunsaturated fats (found in vegetable oils like soybean, corn, and sunflower oils). Aim to increase your polyunsaturated fat intake by about 5% of your total daily calories. This substitution has been shown to reduce heart disease events by 10% for every 5% increase in polyunsaturated fat. You do not need to limit polyunsaturated fats to low levels; studies show benefits even at higher intakes.

High intake of energy-dense foods (high fat and/or sugar) promotes weight gain through passive overconsumption of total energy, whereas high intake of dietary non-starch polysaccharides (fiber) is protective against obesity.

To prevent weight gain, prioritize foods with low energy density, such as vegetables, fruits, legumes, and whole grains (high in fiber/NSP). Be cautious with energy-dense foods, particularly those high in fat and/or sugar, as they promote passive overconsumption of calories. Do not rely on 'low-fat' labels, as these products may be high in sugar and energy-dense. Focus on the volume and fiber content of your food rather than just macronutrient ratios or eating frequency.

Sedentary lifestyles are a convincing risk factor for obesity, and regular physical activity is a convincing protective factor.

Regular physical activity is a convincing protective factor against obesity, and sedentary lifestyles are a convincing risk factor. Aim to increase physical activity and reduce sedentary time as part of a comprehensive obesity prevention strategy.

Once-weekly subcutaneous semaglutide (2.4 mg) combined with lifestyle intervention produces sustained, clinically significant weight loss in adults with overweight or obesity, significantly outperforming placebo.

If you have obesity or overweight with related health conditions, adding once-weekly semaglutide (2.4 mg) to a reduced-calorie diet and exercise program can lead to substantial, sustained weight loss (averaging nearly 15% of body weight) compared to lifestyle changes alone. Be prepared for potential gastrointestinal side effects like nausea, which usually improve over time, and adhere to the titration schedule to minimize discomfort.

Subcutaneous semaglutide at a maintenance dose of 2.4 mg once weekly produces clinically significant weight loss (mean reduction ~14-16%) in non-diabetic adults with obesity or overweight, significantly outperforming placebo.

For non-diabetic adults with obesity or overweight, weekly subcutaneous semaglutide (2.4 mg) is a highly effective treatment for weight loss, achieving an average 15% body weight reduction. This is significantly better than placebo or other existing medications. Treatment involves a gradual dose increase over 16 weeks to minimize side effects, combined with a calorie-restricted diet and exercise. Patients should be aware that stopping the medication often leads to weight regain, suggesting it may be a long-term therapy.

Once-weekly subcutaneous semaglutide (specifically the 2.4 mg dose) produces substantial, sustained weight loss (mean reduction ~14.9%) and significant improvements in cardiometabolic risk factors (HbA1c, lipids, blood pressure) in adults with overweight or obesity, with an acceptable safety profile characterized by mild-to-moderate gastrointestinal side effects.

If you have obesity or overweight with comorbidities, once-weekly semaglutide (2.4 mg) is a highly effective medical treatment that can help you lose nearly 15% of your body weight and improve heart health markers like blood pressure and cholesterol. While you may experience temporary stomach issues like nausea when starting, these usually get better as your body adjusts. It is not a quick fix but a long-term management tool for a chronic condition, comparable to how medication manages high blood pressure.

A nutritional supplement is considered ergogenic only if peer-reviewed human studies demonstrate it significantly enhances exercise performance or muscle hypertrophy with long-term ingestion, not just acute effects or preclinical data.

Do not be misled by supplements that claim to work instantly or are only supported by animal studies. Look for products that have been tested in humans over weeks or months of training. The most reliable supplements are those with long-term efficacy data showing they help you build muscle or perform better consistently over time.

Replacing 5% of daily energy intake from carbohydrates with polyunsaturated fat (PUFA) significantly improves glucose-insulin homeostasis by lowering HbA1c, fasting insulin, and HOMA-IR, and improving insulin secretion capacity.

To improve your blood sugar control and insulin sensitivity, try swapping 5% of your daily calories from carbohydrates (like bread, rice, or sugar) for polyunsaturated fats (found in vegetable oils, nuts, and fish). This specific swap has been shown to lower HbA1c and improve how your pancreas releases insulin. You don't need to eliminate carbs entirely, but prioritizing PUFA over saturated fats or refined carbs when making swaps yields the best metabolic results.

High consumption of dietary sodium increases systolic blood pressure (SBP) and the risk of fatal cardiovascular disease (CVD).

Reduce your sodium intake. High sodium raises blood pressure and increases the risk of fatal heart disease. Aim for lower sodium levels by cooking at home, reading labels, and using herbs and spices for flavor.

High consumption of trans-fats causes an increased risk of coronary heart disease (CHD).

Avoid trans-fats. They are linked to an increased risk of coronary heart disease. Check labels for 'partially hydrogenated oils' and choose foods with healthier fats like olive oil, nuts, and seeds.

Obesity (or preobesity) is a primary upstream risk factor for Type 2 Diabetes, contributing to more than 50% of global T2D disability-adjusted life years.

Excess body weight is the single biggest driver of Type 2 Diabetes risk globally. Losing weight, even modestly, can significantly reduce your risk of developing diabetes and its complications, as it directly addresses the root cause of insulin resistance.

Subcutaneous semaglutide (2.4 mg once weekly) produces significant weight loss (mean 14.9% body weight reduction in STEP 1) and improves cardiometabolic markers (waist circumference, blood pressure, HbA1c, lipids) compared to placebo in adults with obesity.

For adults with obesity, subcutaneous semaglutide (2.4 mg weekly) is a highly effective treatment that reduces body weight by approximately 15% and improves cardiovascular risk factors. It is well-tolerated, though gastrointestinal side effects like nausea are common; these can be mitigated by slow dose escalation and dietary adjustments. It is superior to other weight loss medications in clinical trials.

The one-repetition maximum (1RM) test demonstrates good-to-excellent test-retest reliability across diverse populations, exercise types, and training statuses, making it a valid tool for assessing muscular strength.

Use the 1RM test to measure your maximum strength. It is a reliable tool regardless of your gender, age, or training experience. You do not need multiple familiarization sessions to get a reliable result, and it works for both upper and lower body exercises. Trust the numbers, as they are consistent.

Replacing saturated and trans fats with monounsaturated and polyunsaturated fats significantly reduces the risk of coronary heart disease by improving lipid profiles (lowering LDL, raising HDL, lowering triglycerides) and reducing inflammation and thrombotic tendency.

Focus on the quality of your fats rather than just cutting them out. Replace butter, lard, and processed foods with trans fats with olive oil, nuts, seeds, and fatty fish. This substitution improves your cholesterol profile and reduces heart disease risk more effectively than simply eating 'low-fat' foods high in refined carbohydrates.

Adherence to a traditional Mediterranean dietary pattern, combined with not smoking, maintaining a healthy BMI, and regular physical activity, can prevent over 80% of coronary heart disease, 70% of stroke, and 90% of type 2 diabetes.

Adopt a Mediterranean-style diet rich in vegetables, fruits, whole grains, fish, and olive oil. Combine this with regular physical activity, maintaining a healthy weight, and avoiding smoking. This comprehensive approach is estimated to prevent the majority of heart disease, stroke, and type 2 diabetes cases.

GLP-1 receptor agonists (GLP-1RAs) such as liraglutide and semaglutide facilitate significant weight loss and maintenance by acting on central nervous system receptors to reduce appetite and hunger, increase satiety, and alter food reward pathways, rather than solely through gastrointestinal side effects.

GLP-1 medications like semaglutide (Ozempic/Wegovy) and liraglutide (Saxenda) are highly effective for weight loss because they work on your brain to reduce hunger and increase fullness, not just by making you sick. They are taken by injection, either daily or weekly, and work best when combined with a healthy diet and exercise. Side effects like nausea are common at first but usually go away, and you can manage them by starting with a low dose and increasing it slowly.

Replacing saturated fat with refined carbohydrates provides no cardiovascular benefit, whereas substituting polyunsaturated fats (PUFA) for saturated fat or refined carbohydrates significantly reduces cardiovascular disease risk.

Stop focusing solely on cutting saturated fat. If you reduce saturated fat, make sure you replace it with polyunsaturated fats (like those in nuts, seeds, and vegetable oils) rather than refined carbs (like white bread or sugar). Replacing saturated fat with refined carbs offers no heart benefit, but replacing it with PUFA significantly lowers your risk of heart disease.

Mediterranean dietary patterns supplemented with extra-virgin olive oil or mixed nuts significantly reduce the risk of major cardiovascular events (myocardial infarction, stroke, or death) compared to a control diet reduced in dietary fat.

Adopt a Mediterranean-style diet by adding specific healthy fats. Aim for 50 grams of extra-virgin olive oil or 30 grams of mixed nuts daily. This specific supplementation within a Mediterranean pattern has been shown to reduce heart attacks, strokes, and death by 30% compared to a standard low-fat diet.

Trans fats from partially hydrogenated oils have no safe level of consumption and should be limited as much as possible due to their adverse effects on multiple cardiovascular risk factors.

Avoid trans fats completely. Check food labels for 'partially hydrogenated oils' and avoid products containing them. There is no safe amount of trans fat, and they significantly increase heart disease risk by raising bad cholesterol, lowering good cholesterol, and increasing inflammation.

Once-weekly subcutaneous semaglutide 2.4 mg significantly reduces major adverse cardiovascular events (MACE), heart failure composite endpoints, cardiovascular death, and all-cause death in patients with atherosclerotic cardiovascular disease and obesity, regardless of whether they have heart failure with preserved or reduced ejection fraction.

If you have heart disease and are overweight or obese, especially if you have heart failure, asking your doctor about once-weekly semaglutide (2.4 mg) could significantly lower your risk of heart attacks, strokes, heart failure hospitalizations, and death. This benefit applies whether your heart pumps strongly or weakly, and it is safe to use alongside your current heart failure medications.

Group-based self-management education for Type 2 diabetes significantly improves HbA1c, body weight, waist circumference, triglycerides, and diabetes knowledge compared to usual care or individual education, with effects persisting up to 48 months.

Join a structured group education program for Type 2 diabetes rather than relying solely on individual visits. Look for programs led by health professionals (doctors, dietitians, nurses) or multidisciplinary teams, as these show significant improvements in blood sugar (HbA1c), weight, and knowledge. The benefits can last for years, with HbA1c reductions of 0.3-0.9% observed up to 48 months.

Repeated bouts of mechanical overload (resistance training) induce skeletal muscle hypertrophy primarily through transient increases in mTORC1 signaling, which elevates muscle protein synthesis rates, alongside expanded translational capacity via ribosome biogenesis and increased satellite cell abundance/myonuclear accretion.

To build muscle, you must consistently apply mechanical overload (resistance training) to your muscles. This triggers internal cellular signals (mTORC1) that increase protein synthesis and add new nuclei to muscle fibers. Focus on progressive resistance training over 8-16 weeks to achieve significant mass gains (5-20%). Do not rely solely on hormones or 'pumps'; the mechanical stimulus is the primary driver.

Suboptimal dietary intake is responsible for 70.3% of global incident type 2 diabetes cases, with the largest burdens driven by insufficient whole-grain intake, excess refined rice and wheat, and excess processed meat.

Focus on increasing whole grains, reducing refined grains (rice/wheat), and limiting processed meats. These three factors alone account for the majority of diet-attributable diabetes risk globally.